Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

Company Overview - Generation Bio is a biotechnology company focused on developing therapeutics for T cell-driven autoimmune diseases [3] - The company aims to reprogram T cells in vivo to reduce or eliminate autoreactive T cells that attack the body's own tissues [3] - Generation Bio utilizes cell-targeted lipid nanoparticles (ctLNP) for selective delivery of small interfering RNA (siRNA) to T cells, potentially addressing previously undruggable genes in autoimmunity [3] Upcoming Events - Geoff McDonough, M.D., the president and CEO of Generation Bio, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on April 9th at 12:45 p.m. ET [1] - A live webcast of the presentation will be available on the investor section of the company's website, with a replay accessible for 30 days post-event [2]